TROP2
Clinical trials for TROP2 explained in plain language.
Never miss a new study
Get alerted when new TROP2 trials appear
Sign up with your email to follow new studies for TROP2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for breast cancer brain metastases: targeted drug Trop-2 ADC under study
Disease control Recruiting nowThis study is testing a drug called sacituzumab govitecan (Trop-2 ADC) in 100 breast cancer patients whose cancer has spread to the brain. Researchers want to see if the drug can shrink brain tumors and delay disease progression, while also monitoring side effects. The study coll…
Matched conditions: TROP2
Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New scan could predict lung cancer drug success
Diagnosis Recruiting nowThis study is testing whether a special PET scan using a tracer called 68Ga-MY6349 can predict how well a targeted therapy (Trop2-ADC) works in people with advanced non-small cell lung cancer (NSCLC). Fifty adult patients will receive the scan before and during treatment. The goa…
Matched conditions: TROP2
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated Jun 26, 2026 13:20 UTC